Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

GT Biopharma, Inc. - Common Stock (NQ:GTBP)

0.7062 UNCHANGED
Streaming Delayed Price Updated: 3:59 PM EDT, Oct 6, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 250
Open 0.7062
Bid (Size) 0.7075 (1)
Ask (Size) 0.7169 (383)
Prev. Close 0.7062
Today's Range 0.7062 - 0.7062
52wk Range 0.5500 - 4.100
Shares Outstanding 3,557,502
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Clinical Breakthroughs Converge as Immunotherapy Market Surges Past $136 Billion
EQNX::TICKER_START (NASDAQ:GTBP),(NASDAQ:LPTX),(NASDAQ:IOBT),(NASDAQ:CELC),(NYSE:MAIA) EQNX::TICKER_END 
Via FinancialNewsMedia
12 Health Care Stocks Moving In Wednesday's After-Market Session
 
Via Benzinga

Performance

YTD
-76.0%
-76.0%
1 Month
-18.0%
-18.0%
3 Month
-67.5%
-67.5%
6 Month
-68.8%
-68.8%
1 Year
-65.8%
-65.8%

More News

Read More
Let's uncover which stocks are experiencing notable gaps during today's session.
Via Chartmill
GTBP Stock Earnings: GT Biopharma Reported Results for Q2 2024
Via InvestorPlace
Friday's after hours session: top gainers and losers
Via Chartmill
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
EXCLUSIVE: GT Biopharma Advances Relapsed Blood Cancer Therapy Trial To Cohort 2 After Promising Early Safety Results
Via Benzinga
GT Biopharma Retail Chatter Soars Most Among Biotechs After Financing Strategy Tweak
Via Stocktwits
Topics Regulatory Compliance
Traders are paying attention to the gapping stocks in Tuesday's session.
Via Chartmill
What's going on in today's pre-market session
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
What's Going On With GT Biopharma Stock Tuesday?
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
What's Going On With GT Biopharma Stock?
Via Benzinga
Why Virios Therapeutics Shares Are Trading Lower By Around 48%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga

Frequently Asked Questions

Is GT Biopharma, Inc. - Common Stock publicly traded?
Yes, GT Biopharma, Inc. - Common Stock is publicly traded.
What exchange does GT Biopharma, Inc. - Common Stock trade on?
GT Biopharma, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for GT Biopharma, Inc. - Common Stock?
The ticker symbol for GT Biopharma, Inc. - Common Stock is GTBP on the Nasdaq Stock Market
What is the current price of GT Biopharma, Inc. - Common Stock?
The current price of GT Biopharma, Inc. - Common Stock is 0.7062
When was GT Biopharma, Inc. - Common Stock last traded?
The last trade of GT Biopharma, Inc. - Common Stock was at 10/06/25 03:59 PM ET
What is the market capitalization of GT Biopharma, Inc. - Common Stock?
The market capitalization of GT Biopharma, Inc. - Common Stock is 2.51M
How many shares of GT Biopharma, Inc. - Common Stock are outstanding?
GT Biopharma, Inc. - Common Stock has 3M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.